Off-label

A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.

Ethnographic research sheds light on extensive psychopharmaceutical use by soldiers in post 9/11 U.S. wars.

Industry-funded continuing medical education (CME) influences physicians to prescribe more opioids, focus less on the consequences.

The researchers found that although antidepressants had a slight short-term effect on reducing the likelihood of depression diagnosis, there was no long-term improvement, nor any improvement in motor functioning.

Researchers identify simple ways for clinicians to begin deprescribing conversations.

Study finds that elderly patients taking at least 5 medications were at increased risk of mild cognitive impairment and dementia.

A new study has found that children and adolescents taking a high dose of antipsychotics are almost twice as likely to die of any cause than children on other types of medications.

Benzodiazepine prescription practices may be in response to an epidemic of distress, rather than being used to treat specific mental health diagnoses.

A new study found that prazosin was associated with increased insomnia and nightmares, and did not reduce suicidal thoughts.

Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.

Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.

White race and size of initial prescription, along with poor sleep quality, are associated with long-term benzodiazepine use in older adults.

Two new articles find that rates of ADHD diagnosis and stimulant prescription continue to rise all over the world.

A new study examines the extent to which patterns in prescription drug misuse and substance use disorder symptoms can be predicted by education level

Researchers point to the risks of using antipsychotics with youth and caution against the practice.

New intervention shows promise in reducing over-prescription of off-label antipsychotics in older adults.

Study of students without an ADHD diagnosis finds that stimulants (Adderall) have little impact on cognitive performance.

Three out of four users of the sedative, zolpidem (brand name Ambien), do not follow FDA recommendations to reduce risk.

Study details Medicaid-insured birth cohort’s exposure to psychiatric medications and mental health services.

Results from a Cochrane meta-analysis find that the common practice of prescribing antidepressants to treat insomnia is not supported by current evidence.

From Medical Xpress: A group of 21 prominent physicians have released a comprehensive proposal to guarantee everyone access to safe, innovative, and affordable medication. The proposed reforms...

From Health Affairs: Although the problem of antipsychotic misuse in nursing homes has been raised to policymakers numerous times over the past six decades, the...

Few DTC drug advertisements fully adhere to FDA guidelines, the overall quality of information provided in DTC advertisements is low, and some advertisements market off-label indications.

New research demonstrates that children diagnosed with ADHD at younger ages are more likely than those diagnosed later to receive multiple medications within five years of their diagnosis.

New study finds that pharmaceutical industry gifts to medical providers in Washington D.C. are associated with higher cost, higher volume prescribing behavior.